Remission of hypoplastic acute leukemia by low dose Ara-C: one case report. 1991

S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.

The occurrence of hypoplastic acute leukemia is widely recognized as an atypical leukemia, and is defined as hypocellular marrow with more than 30% blasts and none or few blasts in the circulating blood. The pathogenesis of hypoplastic acute leukemia is still unknown. Clinically, it usually follows a less progressive course and has a high prevalence rate among the elderly. The treatment and prognosis remains unclear. We present a case of hypoplastic acute leukemia, which responded well to low dose Ara-C. The 67 year-old female patient had symptoms of bruising easily and dizziness for about 3 years. Initial investigation revealed pancytopenia in the circulating blood and hypocellularity (10%) with blast cells (60%) in the bone marrow. Besides supportive treatment with blood transfusions and antibiotics, chemotherapy of low dose Ara-C 10 mg/m2 was administrated for 14 days by subcutaneous injection. Bone marrow examination revealed an increase of cellularity and a decrease of blast cells following chemotherapy. Anemia and thrombocytopenia also simultaneously improved. Such results may suggest induction of differentiation effect of low dose Ara-C in hypoplastic leukemia.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
May 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
January 1986, Leukemia research,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
March 1987, British journal of haematology,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
December 2021, Blood advances,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
January 1987, Pediatric hematology and oncology,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
December 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
February 2012, Anticancer research,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
May 2015, Blood,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
May 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
S Y Wei, and S F Lin, and T P Chen, and H W Liu, and C S Chang, and T C Lin
January 1987, Haematology and blood transfusion,
Copied contents to your clipboard!